Adaptive immune responses to SARS-CoV-2 in recovered severe COVID-19 patients

BACKGROUND: There is an imperative need to determine the durability of adaptive immunity to SARS-CoV-2. We enumerated SARS-CoV-2-reactive CD4(+) and CD8(+) T cells targeting S1 and M proteins and measured RBD-specific serum IgG over a period of 2–6 months after symptoms onset in a cohort of subjects...

Descripción completa

Detalles Bibliográficos
Autores principales: Olea, Beatriz, Albert, Eliseo, Torres, Ignacio, Amat, Paula, Remigia, María José, Gozalbo-Rovira, Roberto, Rodríguez-Díaz, Jesús, Buesa, Javier, Blasco, María Luisa, Redón, Josep, Signes-Costa, Jaime, Navarro, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349475/
https://www.ncbi.nlm.nih.gov/pubmed/34391981
http://dx.doi.org/10.1016/j.jcv.2021.104943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349475/
https://www.ncbi.nlm.nih.gov/pubmed/34391981
http://dx.doi.org/10.1016/j.jcv.2021.104943

Ejemplares similares